Two-thirds of patients with moderate or severe plaque psoriasis had complete or nearly complete clearance at 4 months with an ...

利生奇珠单抗是一种人源化、IgG1亚型的单克隆抗体，可以通过与IL-23的p19亚基结合而选择性地拮抗IL-23。IL-23是一种与炎症有关的细胞因子，被认为与 ...

Researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer's ...

AbbVie's IL-23 inhibitor Skyrizi trailed some of its rivals in its first indication psoriasis, but has leapfrogged into first place in Crohn's disease after getting approval for the new indication ...